Innovent Biopharmaceutical Technology (hangzhou) Co., Ltd.

This study is testing a new drug called picankibart to see if it can safely and effectively control moderate-to-severe plaque psoriasis in teenagers. It will involve about 104 adolescents aged 12 to 18. The main goal is to see if the drug significantly clears skin lesions and imp…

This study is testing a new injectable drug called picankibart for people with active psoriatic arthritis, a condition that causes joint pain, swelling, and skin plaques. Over 200 participants will receive either the drug or a placebo injection to see if it safely reduces joint s…

This study is for people with advanced HER2-positive breast cancer that cannot be removed by surgery. It aims to see if a new drug called IBI354, given with or without another drug (pertuzumab), works better and is safer than the current standard first treatment. About 540 partic…